Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: Case report and review of the literature

被引：3

作者：

Arampatzis S. ^{[1
,2
]}

Stefanidis I. ^{[2
]}

Lakiopoulos V. ^{[2
]}

Raio L. ^{[3
]}

Surbek D. ^{[3
]}

Mohaupt M.G. ^{[1
]}

机构：

[1] Department of Nephrology/Hypertension, University of Bern, Berne

[2] Department of Nephrology, University of Thessaly, Larissa

[3] Women's Hospital, University of Bern, Berne

来源：

Thrombosis Journal | / 8卷 / 1期

关键词：

Leave Anterior Descend; Anagrelide; Essential Thrombocythaemia; Coronary Artery Dissection; Early Spontaneous Abortion;

D O I：

10.1186/1477-9560-8-12

中图分类号：

学科分类号：

摘要：

Normal pregnancy corresponds to a procoagulant state. Acute myocardial infarction during pregnancy is rare, yet considering the low non-pregnant risk score of childbearing women it is still surprisingly frequent. We report a case of postpartum recurrent non-ST elevation myocardial infarction in a 40-year-old caucasian woman with essential thrombocythaemia in the presence of a positive JAK-2 mutation and an elevated anti-cardiolipin IgM antibody titer. In the majority of cases of myocardial infarction in pregnancy or in the peripartal period, atherosclerosis, a thrombus or coronary artery dissection is observed. The combination of essential thrombocythaemia and elevated anti-cardiolipin IgM antibody titer in the presence of several cardiovascular risk factors seems to be causative in our case. In conclusion, with the continuing trend of childbearing at older ages, rare or unlikely conditions leading to severe events such as myocardial infarction must be considered in pregnant women.© 2010 Arampatzis et al; licensee BioMed Central Ltd.

引用

共 33 条

[1]

Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M., Essential thrombocythemias. Clinical evolutionary and biological data, Cancer, 58, pp. 2440-2447, (1986)

[2]

Tefferi A., The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview, Mayo Clin Proc, 73, pp. 1177-1184, (1998)

[3]

Murphy S., Peterson P., Iland H., Laszlo J., Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment, Semin Hematol, 34, pp. 29-39, (1997)

[4]

Barbui T., Barosi G., Grossi A., Gugliotta L., Liberato L.N., Marchetti M., Mazzucconi M.G., Rodeghiero F., Tura S., Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation, Haematologica, 89, pp. 215-232, (2004)

[5]

Passamonti F., Rumi E., Pungolino E., Malabarba L., Bertazzoni P., Valentini M., Orlandi E., Arcaini L., Brusamolino E., Pascutto C., Et al., Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia, Am J Med, 117, pp. 755-761, (2004)

[6]

Mitus A.J., Barbui T., Shulman L.N., Rosenthal D.S., Viero P., Cortelazzo S., Schafer A.I., Hemostatic complications in young patients with essential thrombocythemia, Am J Med, 88, pp. 371-375, (1990)

[7]

Tefferi A., Fonseca R., Pereira D.L., Hoagland H.C., A long-term retrospective study of young women with essential thrombocythemia, Mayo Clin Proc, 76, pp. 22-28, (2001)

[8]

Randi M.L., Rossi C., Fabris F., Girolami A., Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies, J Intern Med, 246, pp. 517-518, (1999)

[9]

Passamonti F., Randi M.L., Rumi E., Pungolino E., Elena C., Pietra D., Scapin M., Arcaini L., Tezza F., Moratti R., Et al., Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation, Blood, 110, pp. 485-489, (2007)

[10]

Beressi A.H., Tefferi A., Silverstein M.N., Petitt R.M., Hoagland H.C., Outcome analysis of 34 pregnancies in women with essential thrombocythemia, Arch Intern Med, 155, pp. 1217-1222, (1995)

← 1 2 3 4 →